Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800017283Phase 4Not yet recruiting
Phase 4, open-label trial of dexmedetomidine, oxycodone, propofol and sufentanil in None (2 arms), sponsored by Suqian People's Hospital. Primary endpoints: Respiration, Pulse oxygen saturation and 1 more. Planned start Jul 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800017283.